Tag: medical cannabis

FSD Pharma secures exclusive rights in Canada for line of proprietary products and premium access to cannabinoid science research platform in Israel

MotherlodeTV

FSD Pharma Inc. (the “Company”) (CSE: HUGE), is pleased to announce that its wholly- owned subsidiary FV Pharma Inc (“FV Pharma”) have entered into a strategic alliance with SciCann Therapeutics Inc. (“SciCann”) by executing a binding Memorandum of Understanding  (the “MOU“) dated May 28, 2018, pursuant to which FV Pharma shall invest up to $3M in SciCann for a 15% equity stake. read more

FSD Pharma Announces Listing on the Canadian Securities Exchange

MotherlodeTV

FSD Pharma Inc. (formerly, Century Financial Capital Group Inc., the “Corporation“) is pleased to announce that the Canadian Securities Exchange (“CSE“) has provided final approval to list the Corporation’s class B subordinate voting shares (the “Class B Subordinate Voting Shares“) for trading. Trading of the Class B Subordinate Voting Shares will commence on May 29, 2018 under the symbol “HUGE”. Information about the Corporation can be found in the Corporation’s listing statement dated May 28, 2018, which is located on the Corporation’s profile at www.sedar.com and on the CSE website. read more